Authors: ZAK P CHROBAK L PODZIMEK K PLISKOVA L DEDIC K

Citation: P. Zak et al., DYSERYTHROPOIETIC CHANGES AND SIDEROBLASTIC ANEMIA IN PATIENTS WITH HAIRY-CELL LEUKEMIA BEFORE AND AFTER THERAPY WITH 2-CHLORODEOXYADENOSINE, Neoplasma, 45(4), 1998, pp. 261-265

Authors: ZAK P CHROBAK L PODZIMEK K DULICEK P BLAHA L PLISKOVA L VOGLOVA J MAISNAR V DEDIC K

Citation: P. Zak et al., DYSERYTHROPOIETIC CHANGES IN PATIENTS WITH HAIRY-CELL LEUKEMIA (HCL), British Journal of Haematology, 102(1), 1998, pp. 198-198

Authors: CHROBAK L PODZIMEK K PLISKOVA L KEREKES Z ZAK P VOGLOVA J SPACEK J PALICKA V

Citation: L. Chrobak et al., SERUM-SOLUBLE IL-2 RECEPTOR AS A RELIABLE AND NONINVASIVE MARKER OF DISEASE-ACTIVITY IN PATIENTS WITH HAIRY-CELL LEUKEMIA, Neoplasma, 43(5), 1996, pp. 321-325

Authors: PODZIMEK K KEREKES Z CHROBAK L SKALSKA H VOGLOVA J MIROVA S DULICEK P ZAK P

Citation: K. Podzimek et al., THE VALUE OF BONE-MARROW BIOPSY IN THE PROGNOSIS OF HAIRY-CELL LEUKEMIA (HCL), Neoplasma, 41(6), 1994, pp. 325-330

Authors: CHROBAK L PODZIMEK K KEREKES Z SPACEK J VOGLOVA J

Citation: L. Chrobak et al., LONG-TERM RESULTS IN HAIRY-CELL LEUKEMIA TREATED BY SPLENECTOMY, Neoplasma, 40(2), 1993, pp. 133-136